775 related articles for article (PubMed ID: 21711467)
1. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
[TBL] [Abstract][Full Text] [Related]
2. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
Lahiri K; Malakar S; Sarma N; Banerjee U
Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
4. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
5. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
[TBL] [Abstract][Full Text] [Related]
9. A review of monochromatic excimer light in vitiligo.
Park KK; Liao W; Murase JE
Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
11. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
Verhaeghe E; Lodewick E; van Geel N; Lambert J
Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
Hossani-Madani A; Halder R
G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
[TBL] [Abstract][Full Text] [Related]
14. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
Scherschun L; Kim JJ; Lim HW
J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
[TBL] [Abstract][Full Text] [Related]
15. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
16. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo.
Al-Mutairi N; Manchanda Y; Al-Doukhi A; Al-Haddad A
Dermatol Surg; 2010 Apr; 36(4):499-505. PubMed ID: 20180833
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
20. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
